Caregen Co Ltd
KOSDAQ:214370
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
15 400
30 250
|
Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one Caregen Co Ltd stock under the Base Case scenario is 14 009.76 KRW. Compared to the current market price of 24 150 KRW, Caregen Co Ltd is Overvalued by 42%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Caregen Co Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for Caregen Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Caregen Co Ltd
Balance Sheet Decomposition
Caregen Co Ltd
Current Assets | 96.9B |
Cash & Short-Term Investments | 55.8B |
Receivables | 22.6B |
Other Current Assets | 18.4B |
Non-Current Assets | 145.5B |
Long-Term Investments | 4.5B |
PP&E | 127.1B |
Intangibles | 4.9B |
Other Non-Current Assets | 8.9B |
Current Liabilities | 9.7B |
Accounts Payable | 2.9B |
Accrued Liabilities | 575.3m |
Other Current Liabilities | 6.3B |
Non-Current Liabilities | 9.1B |
Other Non-Current Liabilities | 9.1B |
Earnings Waterfall
Caregen Co Ltd
Revenue
|
77.1B
KRW
|
Cost of Revenue
|
-22.2B
KRW
|
Gross Profit
|
54.8B
KRW
|
Operating Expenses
|
-19.2B
KRW
|
Operating Income
|
35.6B
KRW
|
Other Expenses
|
-1.8B
KRW
|
Net Income
|
33.9B
KRW
|
Free Cash Flow Analysis
Caregen Co Ltd
KRW | |
Free Cash Flow | KRW |
Profitability Score
Profitability Due Diligence
Caregen Co Ltd's profitability score is 67/100. The higher the profitability score, the more profitable the company is.
Score
Caregen Co Ltd's profitability score is 67/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Caregen Co Ltd's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Score
Caregen Co Ltd's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Caregen Co Ltd
According to Wall Street analysts, the average 1-year price target for Caregen Co Ltd is 14 280 KRW with a low forecast of 14 140 KRW and a high forecast of 14 700 KRW.
Dividends
Current shareholder yield for Caregen Co Ltd is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Caregen Co., Ltd. engages in the development of cosmetic products. The company is headquartered in Anyang, Gyeonggi-Do. The company went IPO on 2015-11-17. The firm manufactures HSR CEs which used for improving facial wrinkles and strengthening protect wet under the brand name of Dermaheal, aquashines which used for keeping the shin whitening and promoting skin cells activation under the brand name of REVOFIL, HL CEs which used for treating hair loss, hair filler excell C'rums which used for promoting hair growth and preventing hair lose, LL CEs which used for promoting fat decomposition and prevent fat accumulation, hydra B5 Gels, ultra AW500s, eye filler masks, efficacy raw materials including growth facors and biomimetic peptides, and others. The firm distributes its products within domestic market and to overseas markets.
Contact
IPO
Employees
Officers
The intrinsic value of one Caregen Co Ltd stock under the Base Case scenario is 14 009.76 KRW.
Compared to the current market price of 24 150 KRW, Caregen Co Ltd is Overvalued by 42%.